PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
1734304-1	1992	PET studies were performed to investigate the effects of a new cathechol-O-methyltransferase (COMT) inhibitor, nitecapone (OR-462 [3-(3,4-dihydroxy-5-nitrobenzylidene)- 2,4-pentadione]), on the accumulation of dopamine in the striatum and whether it is able to improve [18F]6-fluorodopa imaging of the brain.	or-462 [3-(3,4-dihydroxy-5-nitrobenzylidene)- 2,4-pentadione	123-183	catechol-O-methyltransferase	Homo sapiens	63-92
1734304-1	1992	PET studies were performed to investigate the effects of a new cathechol-O-methyltransferase (COMT) inhibitor, nitecapone (OR-462 [3-(3,4-dihydroxy-5-nitrobenzylidene)- 2,4-pentadione]), on the accumulation of dopamine in the striatum and whether it is able to improve [18F]6-fluorodopa imaging of the brain.	or-462 [3-(3,4-dihydroxy-5-nitrobenzylidene)- 2,4-pentadione	123-183	catechol-O-methyltransferase	Homo sapiens	94-98